Trial intelligence / Profile preview

Bioequivalence of pramiprexole 0.375 mg sustained-release in healthy Thai volunteers under fed conditions

TCTR20170619001Not yet recruiting

Sponsor
All Research
Start
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of pramipexole in Parkinson's disease (PD) and restless legs syndrome (RLS) (2 arms), sponsored by All Research. Primary endpoints: Cmax, AUC0-t and 1 more. Planned start Aug 2017; status: not yet recruiting.

02

Drugs

pramipexole
03

Conditions

Parkinson's disease (PD)restless legs syndrome (RLS)

Beyond the preview

Go deeper on TCTR20170619001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20170619001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call